Skip to Content

Prestalia Approval History

FDA Approved: Yes (First approved January 21, 2015)
Brand name: Prestalia
Generic name: amlodipine besylate and perindopril arginine
Dosage form: Tablets
Company: Symplmed
Treatment for: High Blood Pressure

Prestalia (amlodipine besylate and perindopril arginine) is a calcium channel blocker and long-acting angiotensin-converting enzyme (ACE) inhibitor combination for the treatment of hypertension.

Development History and FDA Approval Process for Prestalia

DateArticle
Jan 22, 2015Approval FDA Approves Prestalia (amlodipine and perindopril) for Hypertension
Jun 17, 2014FDA Accepts New Drug Application for Symplmed’s Prestalia for the Treatment of Hypertension

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide